GSK3A and acute myeloid leukemia: Phosphorylation was suppressed as CHIR99021 in time‐dependent manner in all AML cell lines (Figure 3C), consistent with the notion that GSK3α/β inhibitors enhance the lysosomal function of AML cell lines through suppression of mTORC1 activity.